EXCLUSIVE-Illumina remedies on Grail bid unconvincing to EU antitrust regulators, sources say
3/3 18:22
U.S. life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has "yet to convince" EU antitrust regulators scrutinising its $8 billion cash-and-stock bid for Grail Inc, people familiar with the matter said....